Company News: Page (1) of 1 - 02/08/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook

Editas Medicine to Participate in Upcoming Investor Conferences

(February 08, 2018)

CAMBRIDGE, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will participate in two upcoming investor conferences. Details are as follows:

BIO CEO & Investor Conference

Date: Monday, February 12, 2018
Forum: Presentation
Time: 1:30 p.m. ET
Location: New York
   
SunTrust Robinson Humphrey 4th Annual Orphan Drug Day
Date: Tuesday, February 13, 2018
Forum: 1x1 Meetings
Location: New York

A live webcast of the presentation will be available on the Investors & Media section of the Editas Medicine website at www.editasmedicine.com. An archived replay will be available for approximately 30 days following the presentation.


About Editas Medicine
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com. 

Contacts

Media:
Cristi Barnett   ?
(617) 401-0113
cristi.barnett@editasmed.com

Investors:
Mark Mullikin
(617) 401-9083
mark.mullikin@editasmed.com


Page: 1


Related Keywords:
Related Sites: Digital Producer ,   Digital Webcast ,   Audio Video Producer ,   Presentation Master ,   Oceania ,   DMN Newswire ,   BN - Webcast ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: DMN Newsletter ,   CMN Newsletter ,   Streamline Newsletter ,   KNews Newsletter ,   Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

Our Privacy Policy --- @ Copyright, 2017 Digital Media Online, All Rights Reserved